Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP)-Reference-Cited by-同舟云学术

Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP)

Published:2017-10-23 Issue:6 Volume:37 Page:722-731
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Mitamura T,Pradeep S,McGuire M,Wu S Y,Ma S,Hatakeyama H,Lyons Y A,Hisamatsu T,Noh K,Villar-Prados A,Chen X,Ivan C,Rodriguez-Aguayo C,Hu W,Lopez-Berestein G,Coleman R L,Sood A K

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2017348.pdf

Reference25 articles.

1. Hillen F, Griffioen AW . Tumour vascularization: sprouting angiogenesis and beyond. Cancer Metastasis Rev 2007; 26: 489–502.

2. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor-growth invivo. Nature 1993; 362: 841–844.

3. Burger RA, Brady MF, Bookman MA, Fleming GF, Monk BJ, Huang H et al. Incorporation of bevacizumab in the primary treatment of ovarian cancer. N Engl J Med 2011; 365: 2473–2483.

4. Perren TJ, Swart AM, Pfisterer J, Ledermann JA, Pujade-Lauraine E, Kristensen G et al. A phase 3 trial of bevacizumab in ovarian cancer. N Engl J Med 2011; 365: 2484–2496.

5. Pujade-Lauraine E, Hilpert F, Weber B, Reuss A, Poveda A, Kristensen G et al. Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial. J Clin Oncol 2014; 32: 1302–1308.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microproteins unveiling new dimensions in cancer;Functional & Integrative Genomics;2024-09-03

2. Possible Strategies to Reduce the Tumorigenic Risk of Reprogrammed Normal and Cancer Cells;International Journal of Molecular Sciences;2024-05-09

3. Identification of Key Candidate Genes Related to Cartilage development during Murine embryonic limb development by single cell RNA-sequencing and Experimental Confirmation;2024-04-16

4. Global Proteomics Analysis of Lysophosphatidic Acid Signaling in PC-3 Human Prostate Cancer Cells: Role of CCN1;International Journal of Molecular Sciences;2024-02-08

5. Elucidating Novel Targets for Ovarian Cancer Antibody–Drug Conjugate Development: Integrating In Silico Prediction and Surface Plasmon Resonance to Identify Targets with Enhanced Antibody Internalization Capacity;Antibodies;2023-10-16